However, it took two years to publish the same molecule for the treatment of ALS/FTD by targeting similar kind tandem repeat, i.e., r(GGGGCC)n in c9orf72 gene (49). The gene discussed is C9orf72; the disease is amyotrophic lateral sclerosis.